Plain-English translation of NCT07146100 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a follow-up study for people with chronic hepatitis B who previously received AHB-137 injection in an earlier clinical trial. Researchers want to see how well the treatment continues to work over time and whether the virus stays controlled. This study does not involve receiving the medication again—it's purely observational to track your health.
For chronic hepatitis B patients who have responded well to treatment, it's important to understand whether the benefits last long-term or if the virus comes back. This study will help doctors know how durable this treatment is and whether people need additional care in the future.
You likely qualify if…
You likely don't qualify if…
Since you previously received treatment in an earlier trial, this study simply follows up with you to check how you're doing over time. You'll likely have periodic visits where researchers check your hepatitis B virus levels and overall health through blood tests and medical assessments. The study doesn't involve receiving the medication again—it's designed to monitor and document whether your response to the previous treatment has held up.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
China